Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akorn to acquire units of Kilitch Drugs
The acquisition occured for about $52m in cash and future contingent payments would total up to nearly $6m. The assets include cGMP manufacturing sites designed for regulated markets,
The acquisition occured for about $52m in cash and future contingent payments would total up to nearly $6m. The assets include cGMP manufacturing sites designed for regulated markets,
The company is installing new equipment in the Luzira based plant as part of their $50 m second phase investment, newvision.co.ug reported. The plant is expected to be
CAT-1004, a chemical entity, is a conjugate of the essential omega-3 fatty acid docosahexaenoic acid (DHA) and salicylate. The trial is intended to assess the safety, tolerability and
Bulimia Nervosa is a binge eating disorder. Currently, Lightlake is focused on providing a safe, effective and simple treatment for patients with Bulimia Nervosa as well as those
Ramelteon works by selectively targeting two melatonin receptors in the brain MT1 and MT2 to regulate body’s sleep-wake cycle and treat insomnia. TGRD Europe has withdrawn its Marketing
The randomized LYM-3001 trial which enrolled 676 patients with relapsed follicular lymphoma received Velcade and rituximab or rituximab alone. The primary endpoint of the trial was progression-free survival
Abraxane, developed using nab technology platform, is a solvent-free chemotherapy treatment option for metastatic breast cancer. The study comprised evaluation of Abraxane in combination with gemcitabine in 67
Cialis inhibits an enzyme, phosphodiesterase type 5 (PDE5), producing vascular relaxation and increased blood flow. Cialis was assessed in a clinical trial program of three placebo-controlled efficacy and
The inhaler, Salmeterol pMDI does not contain Chlorofluorocarbon (CFC) which can cause environmental damage. The product comes in 25mcg per actuation pressurised inhalation, suspension in a green inhaler.
The company has posted a net income of EUR19.2m for the quarter, indicating a rise by 36% ascompared to the corresponding period of the previous year. Adjusted earnings